NCT06476197View on ClinicalTrials.gov

Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy

NACompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

April 3, 2025

Conditions

Cancer Cachexia

Interventions

DEVICE

SAT-003

Device: SAT-003(Software) Using SAT-003 for 12 weeks

Trial Locations (1)

10326

Dongguk University Ilsan Hospital, Ilsan

All Listed Sponsors

lead

S-Alpha Therapeutics, Inc.

INDUSTRY